Yth. Wellness - Testosterone Replacement Therapy (TRT) / Weight loss / Peptides has source-ready treatment evidence for Peptide therapy signal, CJC-1295 evidence, Ipamorelin evidence, PT-141 evidence, Sermorelin evidence, Tesamorelin evidence. Confirm current medication availability, pharmacy model, and pricing before booking.
Yth. Wellness - Testosterone Replacement Therapy (TRT) / Weight loss / Peptides
Type
Provider
Location
Staten Island, New York
Starting At
Rating
4.9/5 (18 reviews)
About This Provider
Yth. Wellness - Testosterone Replacement Therapy (TRT) / Weight loss / Peptides is a provider listed in the GLP1Search directory serving patients in Staten Island, New York. Public listing data includes source-ready evidence for Peptide therapy signal, CJC-1295 evidence, Ipamorelin evidence, PT-141 evidence, Sermorelin evidence, Tesamorelin evidence; confirm current treatment availability directly with the provider.
Visit their website at findyouryth.com for the most current information on pricing, medications, and availability.
Google Reviews
Based on 18 Google reviews
Rating Distribution (estimated)
18 total reviews
Business Details
What Patients Should Know
Before You Start
Confirm total monthly costs upfront — including membership fees, medication costs, and consultation charges. Ask about insurance coverage.
Medication Options
GLP-1 medications include Semaglutide (Ozempic/Wegovy) and Tirzepatide (Mounjaro/Zepbound). Ask which options are available and their sourcing.
Clinical Oversight
Verify your assigned clinician's credentials. Ensure regular check-ins and dose adjustments are part of the program.
Our Independence
GLP1Search does not accept referral fees. All provider data is collected independently from public sources.
Get weekly GLP-1 pricing updates
Provider comparisons, new clinic alerts, and research — delivered to your inbox.
No spam. Unsubscribe anytime.
Not sure which provider is right for you?
Every body is different. Compare pricing, medication options, pharmacy standards, and patient experiences across all 18,771 public provider records, with treatment-evidence and directory-only labels kept separate.